Bubs Australia Announced A Strategic Equity-Linked Alliance With Chemist Warehouse

Bubs Australia Announced A Strategic Equity-Linked Alliance With Chemist Warehouse

Leading producer of goat dairy products, Bubs Australia Limited (ASX: BUB) has signed a binding heads of agreement with the Chemist Warehouse Retail Group, Australia’s largest pharmacy chain network by total sales, to sell Bubs® existing product in Chemist Warehouse pharmacies nationally. Through this agreement, the company will form a four-year strategic alliance relating to the sale and promotion of Bubs® products in Chemist Warehouse stores, commencing 1 June 2019.

Following the release of this news, the share price of the company increased by 7.595% during the intraday trade as on 18 April 2019 (AEST 1:26 PM).

Bubs Australia will surely be benefitted by this relationship with Chemist Warehouse as it will help Bubs in selling its products across Chemist Warehouse retail stores throughout Australia, including its domestic and Tmall online stores. It is expected that Chemist Warehouse will maximise the potential of the Bubs® brand, in return for a marketing and promotional fee charged to Bubs.

Although Chemist Warehouse has been stocking limited ranges of Bubs® products online for some time, through this partnership it will be able to deepen its relationship with Bubs. Further, Chemist Warehouse has also agreed to invest all of the marketing and promotional fees to subscribe for shares in Bubs. Chemist Warehouse is going to use sales and marketing fee to purchase up to 49,426,508 shares in Bubs over three years and initially, Chemist Warehouse will purchase 12,356,627 fully paid ordinary shares in Bubs. Then it will purchase a maximum of 37,069,881 additional Bubs shares, subject to the satisfaction by Chemist Warehouse of certain sales performance targets relating to the actual sales of Bubs® products in Chemist Warehouse stores over a three-year period.

According to Chemist Warehouse Chairman and Co-Founder, Jack Gance, by investing in Bubs, Chemist Warehouse is moving from a conventional supplier-customer relationship to a mutually beneficial long-term partnership to bring the Bubs range to an even wider public. Chemist Warehouse believes that Bubs range of products represents high-quality Australian infant nutrition that Chemist Warehouse’s customers are looking for.

With its key partners in place and a fully vertically integrated business with milk pool security and ownership of its manufacturing facility, Bubs Australia Limited is now ready for rapid global expansion.

Now, let’s have a glance at the company’s stock performance and the return it has posted over the past few months. The stock is trading at a price of $0.850, up by 7.595% during the day’s trade with a market capitalisation of ~$351.42 million as on 18 April 2019. The counter opened the day at $0.835 and reached the day’s high of $0.895 and touched a day’s low of $0.830 with a daily volume of ~ 15,096,695. The stock has provided a year till date return of 73.63% & also posted returns of 51.92%, 83.72% & 2.60% over the past six months, three & one-month period respectively. It had a 52-week high price of $0.940 and touched 52 weeks low of $0.355, with an average volume of ~ 3,652,478.


Disclaimer

This website is a service of Kalkine Media Pty. Ltd. A.C.N. 629 651 672. The website has been prepared for informational purposes only and is not intended to be used as a complete source of information on any particular company. Kalkine Media does not in any way endorse or recommend individuals, products or services that may be discussed on this site. Our publications are NOT a solicitation or recommendation to buy, sell or hold. We are neither licensed nor qualified to provide investment advice.

Top 25 Dividend Stocks report for April

People prefer a dividend stock in their portfolio as it possesses the feature of compounding. Compounding means that the earning which is generated through these dividend stock will get reinvested and will eventually create earnings from earning. More precisely, the dividend generated from these dividend stock will get reinvested to buy another set of a share of the dividend stock which results in giving a higher dividend.

Click here to download your top 25 dividend stocks report!

6 Cannabis Stocks under Investor’s Limelight…

Cannabis companies that sell both medicinal weed and recreational pot. Marijuana stocks to look at. Marijuana mergers and acquisitions. Dispensary data analytics. Upcoming marijuana IPO’s Those phrases have become increasingly common as marijuana legalization spreads.

Global spending on legal cannabis is expected to grow 230% to $32 billion in 2020 as compared to $9.5 in 2017, according to Arcview Market Research and BDS Analytics. As of June 29, 2018 the United States Marijuana Index, despite a lot of uncertainty around regulations, has over the past 1 year gained 71.49%, as compared to about 12% gain seen by the S&P 500.

Click here for your FREE Report

LEAVE A REPLY

Please enter your comment!
Please enter your name here